Stoke Therapeutics logo

Stoke Therapeutics Share Price Today

(NASDAQ: STOK)

Stoke Therapeutics share price is $7.69 & ₹657.23 as on 18 Apr 2025, 2.30 'hrs' IST

$7.69

0.13

(1.72%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Stoke Therapeutics share price in Dollar and Rupees. Guide to invest in Stoke Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Stoke Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Stoke Therapeutics share price movements

  • Today's Low: $7.34
    Today's High: $7.72

    Day's Volatility :4.86%

  • 52 Weeks Low: $5.35
    52 Weeks High: $17.58

    52 Weeks Volatility :69.57%

Stoke Therapeutics (STOK) Returns

PeriodStoke TherapeuticsSector (Health Care)Index (Russel 2000)
3 Months
-21.53%
-2.8%
0.0%
6 Months
-38.87%
-11.0%
0.0%
1 Year
-36.18%
-1.9%
0.0%
3 Years
-56.33%
-1.5%
-12.9%

Stoke Therapeutics (STOK) Key Statistics

in dollars & INR

Previous Close
$7.56
Open
$7.55
Today's High
$7.715
Today's Low
$7.34
Market Capitalization
$415.9M
Today's Volume
$837.5K
52 Week High
$17.58
52 Week Low
$5.35
Revenue TTM
$36.6M
EBITDA
$-99.2M
Earnings Per Share (EPS)
$-1.65
Profit Margin
-243.42%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-45.8%

How to invest in Stoke Therapeutics Stock (STOK) from India?

It is very easy for Indian residents to invest directly in Stoke Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Stoke Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Stoke Therapeutics or STOK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Stoke Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Stoke Therapeutics shares which would translate to 0.111 fractional shares of Stoke Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Stoke Therapeutics, in just a few clicks!

Returns in Stoke Therapeutics (STOK) for Indian investors in Rupees

The Stoke Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Stoke Therapeutics investment value today

Current value as on today

₹66,158

Returns

₹33,842

(-33.84%)

Returns from Stoke Therapeutics Stock

₹36,183 (-36.18%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Stoke Therapeutics (STOK)

-41%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Stoke Therapeutics Stock from India on INDmoney has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Stoke Therapeutics

  • Skorpios Trust

    12.77%

  • BlackRock Inc

    10.89%

  • RTW INVESTMENTS, LLC

    9.47%

  • Baker Bros Advisors LP

    8.57%

  • Redmile Group, LLC

    8.49%

  • Morgan Stanley - Brokerage Accounts

    6.36%

Analyst Recommendation on Stoke Therapeutics

Rating
Trend

Buy

    86%Buy

    13%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Stoke Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Stoke Therapeutics Stock (STOK)

What analysts predicted

Upside of 210.47%

Target:

$23.88

Current:

$7.69

Insights on Stoke Therapeutics Stock (Ticker Symbol: STOK)

  • Price Movement

    In the last 7 days, STOK stock has moved up by 7.7%
  • Increasing Revenue

    Revenue is up for the last 5 quarters, 2.80M → 22.61M (in $), with an average increase of 31.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -26.43M → -10.48M (in $), with an average increase of 152.2% per quarter
  • STOK vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 113.4%
  • STOK vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 88.7%
  • Price to Sales

    ForSTOK every $1 of sales, investors are willing to pay $11.4, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Stoke Therapeutics Technicals Summary

Sell

Neutral

Buy

Stoke Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Stoke Therapeutics (STOK) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Stoke Therapeutics logo
-9.24%
-38.87%
-36.18%
-56.33%
-64.46%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Stoke Therapeutics

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase I/II clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
Organization
Stoke Therapeutics
Employees
128
CEO
Mr. Ian F. Smith A.C.A., C.P.A.
Industry
Health Technology

Management People of Stoke Therapeutics

NameTitle
Dr. Arthur O. Tzianabos Ph.D.
Interim Executive Chairman
Mr. Ian F. Smith A.C.A., C.P.A.
Interim CEO & Director
Dr. Adrian R. Krainer Ph.D.
Co-Founder & Independent Director
Dr. Edward M. Kaye M.D., Ph.D.
Advisor & Director
Dr. Barry S. Ticho FACC, M.D., Ph.D.
Chief Medical Officer
Ms. Isabel Aznarez Ph.D.
Co-Founder, Head of Research & Senior VP
Mr. Thomas Edward Leggett
Chief Financial Officer
Mr. Jonathan Allan J.D.
Corporate Secretary & General Counsel
Ms. Dawn Kalmar
Chief Communications Officer
Ms. Joan Wood
Chief Human Resources Officer

Important FAQs about investing in STOK Stock from India :

What is Stoke Therapeutics share price today?

Stoke Therapeutics share price today stands at $7.69, Open: $7.55 ; Previous Close: $7.56 ; High: $7.72 ; Low: $7.34 ; 52 Week High: $17.58 ; 52 Week Low: $5.35.

The stock opens at $7.55, after a previous close of $7.56. The stock reached a daily high of $7.72 and a low of $7.34, with a 52-week high of $17.58 and a 52-week low of $5.35.

Can Indians buy Stoke Therapeutics shares?

Yes, Indians can invest in the Stoke Therapeutics (STOK) from India.

With INDmoney, you can buy Stoke Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Stoke Therapeutics at zero transaction cost.

How can I buy Stoke Therapeutics shares from India?

It is very easy to buy Stoke Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Stoke Therapeutics (STOK) be purchased?

Yes, you can buy fractional shares of Stoke Therapeutics with INDmoney app.

What are the documents required to start investing in Stoke Therapeutics stocks?

To start investing in Stoke Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Stoke Therapeutics Stock (STOK)?

Today’s highest price of Stoke Therapeutics (STOK) is $7.72.

Today’s lowest price of Stoke Therapeutics (STOK) is $7.34.

What is today's market capitalisation of Stoke Therapeutics?

Today's market capitalisation of Stoke Therapeutics STOK is 415.9M

What is the 52 Week High and Low Range of Stoke Therapeutics Stock (STOK)?

  • 52 Week High

    $17.58

  • 52 Week Low

    $5.35

What are the historical returns of Stoke Therapeutics (STOK)?

  • 1 Month Returns

    -9.24%

  • 3 Months Returns

    -38.87%

  • 1 Year Returns

    -36.18%

  • 5 Years Returns

    -64.46%

Who is the Chief Executive Officer (CEO) of Stoke Therapeutics ?

Mr. Ian F. Smith A.C.A., C.P.A. is the current Chief Executive Officer (CEO) of Stoke Therapeutics.